Rationale and Design of the PE-TRACT Trial – A Multicenter Randomized Trial to Evaluate Catheter-Directed Therapy for the Treatment of Intermediate-Risk Pulmonary Embolism

By sjmartinez • December 6, 2024

Sista AK, Troxel AB, Tarpey T, Parpia S, Goldhaber SZ, Stringer WW, Magnuson EA, Cohen DJ, Kahn SR, Rao SV, Morris TA, Goldfeld KS, Vedantham S. Rationale and Design of the PE-TRACT Trial - A Multicenter Randomized Trial to Evaluate Catheter-Directed Therapy for the Treatment of Intermediate-Risk Pulmonary Embolism. Am Heart J. 2024 Dec 3:S0002-8703(24)00319-3. doi: 10.1016/j.ahj.2024.11.016. Epub ahead of print. PMID: 39638275.

Tags: Harbor UCLA, Publications, Pulmonary, Critical Care & Sleep Medicine

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

Oshima A, Serruys PW, Garg S, McEvoy JW, Wood DA, Doenst T, Taggart DP, Puskas JD, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai[...]

Microbiome Signatures in Advanced Gastric Cancer: Emerging Biomarkers for Risk Stratification, Therapy Guidance, and Prognostic Insight

Kim KJ, Zhong H, Tai D, Shah P, Park D, Goes V, Li J, Jung C, Kim L, Guzman S, Brar G, Castillo D. Microbiome[...]

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]